Biosimilars are an opportunity to help reduce the burden of rising treatment costs.

Diversity drives innovation, which in turn drives change and progress.

At Sandoz our work is focused on improving access to medicines, access to medical information and access ...

Sandoz announced a commitment of $10 million USD in medicines to Americares.

Explore Novartis

Featured / Jan 27

Novartis 2019 Financial Results

Novartis announces fourth quarter and full year financial results for 2019 at 07:00 CET on January 29, 2020.

See our product listing, including: NDCs, Size, Dosage Forms and more.